Health Condition 1: N719- Inflammatory disease of uterus, unspecified
Conditions
Interventions
Intervention1: ââ??? ââ?¬Å?Group Aââ?¬?ââ?¬â? Properative TAP block: Group A will receive TAP block after Induction of general anesthesia before incision with , Inj bupivacaine 0.25% 20ml in Int
Sponsors
RRMCH
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA I to II Patients of female sex. 2.Aged between 18 to 60 years. 3 Undergoing Elective laparoscopic gynaecology surgery- LAVH/TLH
Exclusion criteria
Exclusion criteria: a)Patients with history of allergy to local anesthetics b)Patients with history of mental disorders. c)Patient Refusal. d)Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders. e)Infection at site of procedure f)Surgery more than 3 hours duration g)ASA III and IV.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the effectiveness of preoperative TAP block for Intra-operative analgesia in patients undergoing Laparoscopic gynaecological surgeries.Timepoint: To Note VAS score at 0,2,4,6,8,10,12,14,16,18,24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare total intraoperative opiod consumption in both groups Intraoperative Muscle relaxant and volatile anesthetic consumption. Hemodynamic parameterTimepoint: 15,30,45,60,75,90,120,180 minutes intraoperatively and 1,2,4,8,12,24 hours postoperatively | — |
Countries
India
Contacts
Public ContactDr Kishore Kumar
Rajarajeswari Medical college and Hospital
Outcome results
None listed